Congenital cardiac diseases are the most frequent congenital malformations.Reference Buendía, Calderón-Colmenero and Patiño-Bahena1, Reference Samanek2 The definition most commonly used to describe them, proposed by Mitchell et al,Reference Mitchell, Korones and Berrendees3 states that it refers to an evident structural anomaly of the heart or of the large intrathoracic vessels with a real or potential repercussion. The reported prevalence of congenital cardiac disease for 1000 live births goes from 2.1 in New England in the United States of America, 2.17 in Toronto in Canada to 10.6 in Japan, and 12.3 in Florence in Italy.Reference Fyler4, Reference Martínez-Olorón, Romero and Alzina de Aguilar5 The prevalence of congenital cardiac disease in Mexico is unknown, but it can be said that it is the second cause of mortality in infants under 1 year of age.Reference Venegas, Peña-Alonso and Lozano6, 7
In Mexico, an analysis of 2257 patients with congenital cardiopathy performed at the Cardiology Hospital of the National Medical Center Siglo XXI revealed that patent ductus arteriosus represented 20% of all cases, followed by interatrial communication with 16.8%, interventricular communication with 11%, tetralogy of Fallot and pulmonary atresia with ventricular septal defect with 9.3%, aortic coarctation and pulmonary stenosis with 3.6% each, and total anomalous connection of pulmonary veins with 3%.Reference Alva Espinosa8, Reference Calderón-Colmenero, Cervantes-Salazar, Curi-Curi and Ramirez-Marroquin9 The classical observed pathophysiological patterns in the paediatric population are the volume and pressure overload, as congenital cardiac disease depicts a high degree of variability, not only in cardiac malformations, but also in clinical manifestations.
Elasticity and distensibility are altered in the presence of aortic vascular calcification, which increases the workload of the heart and triggers cardiac failure.Reference Demer and Tintut10
Mineralisation is a biological process in which many of the minerals found in the vascular wall correspond to calcium and phosphates (hydroxyapatite); however, many other minerals such as silicium and iron can also be found.Reference Chapman11
Vascular and bone mineralisation share physiological mechanisms that reflect the similarity of the paracrine signals coming from the osteoblasts, condrocytes, and osteoclasts. Inflammation, turbulent blood flow, hyperphosphataemia, lysis of elastin, and oxidative stress all favour remodellation of the vascular matrix through an increment in the synthesis of bone morphogenetic protein-2, -4, and Wnt signalling cascade. In addition, these pathological processes also deteriorate the mechanisms that limit mineral deposits, such as inhibiting the osteochondrogenetic differentiation and depuration of the vesicular matrix.Reference Shao, Cai and Towler12
Even if mineralisation of tissues is recognised as a consequence of the inflammation generated by metabolic, mechanical, haemodynamic, and/or infectious disorders, and is generally associated with advanced age,Reference Katz, Wong and Kronmal13 children with different congenital cardiac disease could present diverse degrees of vascular mineralisation influencing cardiovascular function. On the other hand, volume and pressure overloads, characteristic of the different cardiopathies, could favour the development of vascular mineralisation. Therefore, our objective was to determine the presence and degree of vascular mineralisation in samples of the ascending and descending aorta in children with diverse congenital cardiac disease.
Materials and methods
We conducted a cross-sectional study, analysing vascular tissue from 17 children with complex congenital cardiopathies. Table 1 shows the age and type of complex congenital cardiopathies included in the analysis.
Age and type of complex congenital cardiopathy of the patients included in the study.
Vascular tissues were obtained from autopsies at the Instituto Nacional de Cardiología “Ignacio Chávez”. We dissected sections of 0.5 centimetres of the ascending and descending aorta.
The aorta sections, preserved in formaldehyde, were dried at room temperature for 24–48 hours and placed on glass coverslips, covered with graphite, and studied under a scanning electron microscope, Japanese Electronic and Optical Laboratory, Model JEOL JXA8900-R, with an energy-dispersive X-ray spectrometer, at an acceleration voltage of 20 kilo electro volt, an acquisition time of 30–60 seconds, and a 20 nanoampere current. Digital images are obtained with a resolution of 1024 × 1024 pixels. The images of this mapping were processed with the IMAGE-PRO PLUS 4.1 software; the mineral deposits contrast with the image background. To avoid bias, the same dimension of a 100 square micrometre area was always analysed.
Statistical analysis
Data are expressed as mean, that is, standard error. Groups were compared with the t-test for paired samples and differences were considered significant if p value was less than or equal to 0.5.
The study was conducted with the approval of the Review Board of the National Institute of Cardiology, México.
Results
Our comparison of the presence of minerals in the ascending aorta with a mean of 23.07, Figure 1, with that of the descending aorta with a mean of 11.38, Figure 2, of patients with congenital cardiac disease also revealed statistically significant differences in p value equal to 0.036, with a greater amount of minerals in the ascending aorta.
Minerals in the ascending aorta.
Minerals in the descending aorta.
Table 2 shows different types of minerals found in the ascending and the descending aortas. Results are in percentage of every element per studied field. Results are expressed in percentage of weight ratios of each mineral.
Mineralisation according to chemical element in the descending and ascending aorta of the patients with congenital cardiopathy.
Results are expressed in percentage of weight ratios of each mineral
Table 3 provides the energy-dispersive X-ray spectrometer of the corresponding Figures 1 and 2. Results are expressed in percentage of weight ratios of each mineral.
Discussion
The use of the electron probe microanalysisReference Flegler, Heckman and Klomparens14 allowed us to recognise the presence of different minerals in the studied aortic tissues. The technique consists of bombarding the sample with an electron beam in a high-vacuum electronic column; the signals emitted by the sample are semi-quantitatively analysed through energy-dispersive X-ray spectroscopy, which detects the dispersion of the characteristic X-rays of the different elements constituting the sample. It enables the identification of the chemical composition of solid materials without destroying them at very low concentrations, in the order of 0.2% for the analysis to be reliable, by comparing the characteristic energy of the X-rays of the sample with that of reference standards or internal patterns of the instrument.
This technological resource is issued mainly in geophysics and palaeontology, but as far as we know it is the most sensitive method to quantify minerals in a tissue. With just one determination, the content of the different minerals can be obtained, as it has a high sensitivity and spatial resolution and can be applicable in the realm of vascular mineralisation studies in the future.
Results show a higher degree of vascular mineralisation in the ascending aorta than in descending aorta of the children with complex congenital cardiopathy.
Congenital cardiac diseases, from a haemodynamic point of view, are characterised by a volume overload in the ascending aorta. The haemodynamic demand of the cardiovascular system requires the aorta to store energy during systole and to release it during diastole, while minimising cardiac work. The loss of elasticity and aortic performance fostered by the aortic vascular mineralisation increases the speed of the arterial pulse wave, resulting in increased systolic pressure. This also increases cardiac work, promoting left ventricular hypertrophy, cardiac failure, and diastolic dysfunction.Reference Demer and Tintut10
It has been described that mineralisation, predominantly by the presence of calcium in the ascending aorta, originates ejection resistance by the left ventricle, mainly due to the loss of elasticity at the root of the aorta, thus promoting ventricular hypertrophy, diastolic dysfunction, and cardiac failure, independently from the presence of other factors.Reference Takasu, Katz and Nasir15, Reference Anand, Lim and Bassett16 In contrast to the children with congenital cardiac disease, vessel calcification in adults with atherosclerosis is found mainly in the root and in the aortic arch, and less frequently in the descending aorta. It is considered that the most influential factors are variations in the ejection pressure of the left ventricle, alterations in systemic pressure, and the mechanical disorders of the aortic valve.
Our results are in accordance with those of Krefting et al,Reference Krefting, Röhrig and Bröcker17 who studied the presence of minerals in patients with coarctation of the aorta and found different elements: Na, Mg, P, S, Cl, K, and Ca. These authors described that Ca and P were higher in the ascending aorta, which, anatomically, is subjected to a greater pressure.
On the other hand, the studied patients with complex congenital malformations present tissular hypoxia, which could contribute to the vascular mineralisation mechanism. It has been demonstrated in pre-osteocyte cultures that bone mineralisation decreases in a hypoxic environmentReference Zahm, Bucaro and Srinivas18 and favours a similar mechanism described in osteoporosis, in which the deposit of minerals decreases in the bone tissue and the vascular deposit increases.Reference Abedin, Tintut and Demer19 It is necessary to develop more studies to elucidate this hypothesis.
Conclusion
The ascending aorta of children with complex congenital cardiopathy shows a high degree of vascular mineralisation as compared with the descending aorta without differing in the type of mineral elements.
Acknowledgements
This work received financing from CONACYT grant SEP-CONACYT 2006-59896, DGAPA UNAM grant IN220308, and the Instituto Científico Pfizer. None of the authors have competing interest with regard to this research. All authors contributed extensively and equally to this work.
